SPINK4 modulates inhibition of glycolysis against colorectal cancer progression
Dysregulation of glycolysis is frequently linked to aggressive tumor activity in colorectal cancer (CRC). Although serine peptidase inhibitor, Kazal type 4 (SPINK4) has been linked to CRC, its exact linkage to glycolytic processes and gene expression remains unclear. Differentially expressed genes...
Збережено в:
| Автори: | , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina
2024-05-01
|
| Серія: | Biomolecules & Biomedicine |
| Предмети: | |
| Онлайн доступ: | https://www.bjbms.org/ojs/index.php/bjbms/article/view/10338 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|